Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
Reinhold Kreutz, Professor of Clinical Pharmacology and Hypertension at Charite, Past President of the European Society of Hypertension, shared on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Internal Medicine, adding:
”Excited to share our new paper on cardiovascular complications in acute intermittent porphyria (AIP)!
Our study highlights another important link between hypertension and a rare but clinically significant condition associated with multiple cardiometabolic and cardiovascular complications.
We found that patients with AIP have a markedly higher prevalence of hypertension, abnormal nocturnal blood pressure profiles, and cardiac structural changes, with rising even further during acute attacks.
These findings reinforce the need for greater awareness of cardiovascular risk assessment and long-term monitoring in patients with AIP.
Hypertension in rare metabolic diseases may still be underrecognized, yet it could play a key role in future clinical management, multidisciplinary care, and research directions.
Proud to collaborate with an outstanding international team on this work.”
Title: Hypertension and blood pressure profiles in patients with acute intermittent porphyria: a prospective case-control study
Authors: Krzysztof Jaworski, Robert Wasilewski, Jerzy Windyga, Ilona Kowalik, Hanna Szwed, Agnieszka Lipniacka, Magdalena Niedolistek, Joanna Was, Andrzej Januszewicz, Reinhold Kreutz, Franz Messerli, Rafal Dabrowski

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization